778 related articles for article (PubMed ID: 29149179)
1. Postmenopausal hormone therapy and risk of stroke: A pooled analysis of data from population-based cohort studies.
Carrasquilla GD; Frumento P; Berglund A; Borgfeldt C; Bottai M; Chiavenna C; Eliasson M; Engström G; Hallmans G; Jansson JH; Magnusson PK; Nilsson PM; Pedersen NL; Wolk A; Leander K
PLoS Med; 2017 Nov; 14(11):e1002445. PubMed ID: 29149179
[TBL] [Abstract][Full Text] [Related]
2. The route of administration, timing, duration and dose of postmenopausal hormone therapy and cardiovascular outcomes in women: a systematic review.
Oliver-Williams C; Glisic M; Shahzad S; Brown E; Pellegrino Baena C; Chadni M; Chowdhury R; Franco OH; Muka T
Hum Reprod Update; 2019 Mar; 25(2):257-271. PubMed ID: 30508190
[TBL] [Abstract][Full Text] [Related]
3. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
4. Long-term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A; Lee J
Cochrane Database Syst Rev; 2017 Jan; 1(1):CD004143. PubMed ID: 28093732
[TBL] [Abstract][Full Text] [Related]
5. Hormone therapy and coronary heart disease: the role of time since menopause and age at hormone initiation.
Grodstein F; Manson JE; Stampfer MJ
J Womens Health (Larchmt); 2006; 15(1):35-44. PubMed ID: 16417416
[TBL] [Abstract][Full Text] [Related]
6. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
7. Transdermal hormone therapy and the risk of stroke and venous thrombosis.
Speroff L
Climacteric; 2010 Oct; 13(5):429-32. PubMed ID: 20670199
[TBL] [Abstract][Full Text] [Related]
8. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy.
Grodstein F; Manson JE; Stampfer MJ; Rexrode K
Arch Intern Med; 2008 Apr; 168(8):861-6. PubMed ID: 18443262
[TBL] [Abstract][Full Text] [Related]
9. Age at natural menopause and risk of incident cardiovascular disease: a pooled analysis of individual patient data.
Zhu D; Chung HF; Dobson AJ; Pandeya N; Giles GG; Bruinsma F; Brunner EJ; Kuh D; Hardy R; Avis NE; Gold EB; Derby CA; Matthews KA; Cade JE; Greenwood DC; Demakakos P; Brown DE; Sievert LL; Anderson D; Hayashi K; Lee JS; Mizunuma H; Tillin T; Simonsen MK; Adami HO; Weiderpass E; Mishra GD
Lancet Public Health; 2019 Nov; 4(11):e553-e564. PubMed ID: 31588031
[TBL] [Abstract][Full Text] [Related]
10. Menopause and postmenopausal hormone therapy and risk of hearing loss.
Curhan SG; Eliassen AH; Eavey RD; Wang M; Lin BM; Curhan GC
Menopause; 2017 Sep; 24(9):1049-1056. PubMed ID: 28486246
[TBL] [Abstract][Full Text] [Related]
11. A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease.
Grodstein F; Manson JE; Colditz GA; Willett WC; Speizer FE; Stampfer MJ
Ann Intern Med; 2000 Dec; 133(12):933-41. PubMed ID: 11119394
[TBL] [Abstract][Full Text] [Related]
12. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause.
Rossouw JE; Prentice RL; Manson JE; Wu L; Barad D; Barnabei VM; Ko M; LaCroix AZ; Margolis KL; Stefanick ML
JAMA; 2007 Apr; 297(13):1465-77. PubMed ID: 17405972
[TBL] [Abstract][Full Text] [Related]
13. Does menopausal hormone therapy reduce myocardial infarction risk if initiated early after menopause? A population-based case-control study.
Carrasquilla GD; Berglund A; Gigante B; Landgren BM; de Faire U; Hallqvist J; Leander K
Menopause; 2015 Jun; 22(6):598-606. PubMed ID: 25490112
[TBL] [Abstract][Full Text] [Related]
14. Menopausal hormone therapy and cancer risk: An overestimated risk?
Simin J; Tamimi R; Lagergren J; Adami HO; Brusselaers N
Eur J Cancer; 2017 Oct; 84():60-68. PubMed ID: 28783542
[TBL] [Abstract][Full Text] [Related]
15. Risk of venous thromboembolism associated with local and systemic use of hormone therapy in peri- and postmenopausal women and in relation to type and route of administration.
Bergendal A; Kieler H; Sundström A; Hirschberg AL; Kocoska-Maras L
Menopause; 2016 Jun; 23(6):593-9. PubMed ID: 27023862
[TBL] [Abstract][Full Text] [Related]
16. Different menopausal hormone regimens and risk of breast cancer.
Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
[TBL] [Abstract][Full Text] [Related]
17. Methods and baseline cardiovascular data from the Early versus Late Intervention Trial with Estradiol testing the menopausal hormone timing hypothesis.
Hodis HN; Mack WJ; Shoupe D; Azen SP; Stanczyk FZ; Hwang-Levine J; Budoff MJ; Henderson VW
Menopause; 2015 Apr; 22(4):391-401. PubMed ID: 25380275
[TBL] [Abstract][Full Text] [Related]
18. Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study.
MacLennan AH; Henderson VW; Paine BJ; Mathias J; Ramsay EN; Ryan P; Stocks NP; Taylor AW
Menopause; 2006; 13(1):28-36. PubMed ID: 16607096
[TBL] [Abstract][Full Text] [Related]
19. Association Between Hormone Therapy and Muscle Mass in Postmenopausal Women: A Systematic Review and Meta-analysis.
Javed AA; Mayhew AJ; Shea AK; Raina P
JAMA Netw Open; 2019 Aug; 2(8):e1910154. PubMed ID: 31461147
[TBL] [Abstract][Full Text] [Related]
20. Hormone therapy and ovarian cancer.
Mørch LS; Løkkegaard E; Andreasen AH; Krüger-Kjaer S; Lidegaard O
JAMA; 2009 Jul; 302(3):298-305. PubMed ID: 19602689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
